MetaVia Inc.
MTVA Nasdaq· Pharmaceutical Preparations
Last close · Oct 23, 2026
$1.38
KIRA · Stoqly’s AI analyst, in plain words
- MetaVia Inc. had $0.5M of revenue in fiscal 2025, down 44.6% on the year before. Over five years, revenue changed +67.2% a year on average.
- Its operating margin was −2,687.8%, up 443.6 pts: of every 100 in sales, about −2,688 is left after running the business.
- MetaVia Inc. lost $13.0M in fiscal 2025.
- Free cash flow was −$15.7M in fiscal 2025, −3,079.0% of revenue.
Market cap
$8.2M
P/E
—
Revenue
$0.5M
Net income
−$13.0M
Free cash flow
−$15.7M
Operating margin
−2,687.8%
MetaVia Inc. in 30 seconds · fiscal 2025
Are sales growing?
−44.6%
No. Sales fell 44.6% last year.
Does it make a profit?
−2,543.7%
No. It lost money last year.
Does profit turn into cash?
−3,079.0%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 7
Weak. It passes 1 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What MetaVia Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 26, 2026
- Legal name
- MetaVia Inc.
- CIK
- 0001638287
MetaVia Inc. · MTVA
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $0.0M | — | $0.5M | $0.9M | $0.5M |
| Revenue growth | −64.1% | — | — | 99.6% | −44.6% |
| Net interest income | $0.0M | — | $0.5M | $0.9M | $0.5M |
| Operating margin | −109,271.4% | — | −3,446.0% | −3,131.4% | −2,687.8% |
| Net income | −$15.3M | −$14.0M | −$12.5M | −$27.6M | −$13.0M |
| Net margin | −109,171.4% | — | −2,705.0% | −2,999.1% | −2,543.7% |
| Diluted EPS | −$19.81 | −$43.42 | −$2.46 | −$39.13 | −$7.35 |
| Cash | |||||
| Cash from operations | −$15.1M | −$11.7M | −$10.8M | −$24.7M | −$15.7M |
| Capital expenditure | $0.0M | — | $0.1M | $0.0M | $0.0M |
| Free cash flow | −$15.1M | — | −$10.8M | −$24.7M | −$15.7M |
| FCF margin | −108,121.4% | — | −2,353.4% | −2,686.7% | −3,079.0% |
| Share count change | −95.2% | −58.3% | 1,476.3% | −86.1% | 150.4% |
| Debt and strength | |||||
| Cash and short-term investments | $16.4M | $33.4M | $22.4M | $16.0M | $10.3M |
| Shareholders' equity | $14.6M | $21.8M | $16.7M | $7.9M | $5.3M |
| Current ratio | 7.7x | 2.8x | 3.8x | 1.9x | 1.9x |
| Returns and quality | |||||
| Return on equity | −140.2% | −76.9% | −64.9% | −224.2% | −195.6% |
| Return on tangible equity | −104.7% | −64.2% | −74.7% | −347.9% | −243.3% |
| Piotroski F-score | 4 | — | — | 3 | 1 |
| Altman Z'' | −9.4 | −7.1 | −12.5 | −35.0 | −47.9 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
MetaVia Inc. · MTVA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.38 a share, the company is worth $8.2M.
Source: SEC EDGAR XBRL filings (CIK 0001638287). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.